Back to Search
Start Over
Universal Hepatitis B Vaccination in Adults Aged 19-59 Years: Updated Recommendations of the Advisory Committee on Immunization Practices - United States, 2022.
- Source :
-
MMWR: Morbidity & Mortality Weekly Report . 4/1/2022, Vol. 71 Issue 13, p477-483. 7p. 1 Chart, 1 Graph. - Publication Year :
- 2022
-
Abstract
- Hepatitis B (HepB) vaccines have demonstrated safety, immunogenicity, and efficacy during the past 4 decades (1,2). However, vaccination coverage among adults has been suboptimal, limiting further reduction in hepatitis B virus (HBV) infections in the United States. This Advisory Committee on Immunization Practices (ACIP) recommendation expands the indicated age range for universal HepB vaccination to now include adults aged 19-59 years. Removing the risk factor assessment previously recommended to determine vaccine eligibility in this adult age group (2) could increase vaccination coverage and decrease hepatitis B cases. [ABSTRACT FROM AUTHOR]
Details
- Language :
- English
- ISSN :
- 01492195
- Volume :
- 71
- Issue :
- 13
- Database :
- Academic Search Index
- Journal :
- MMWR: Morbidity & Mortality Weekly Report
- Publication Type :
- Academic Journal
- Accession number :
- 156093675
- Full Text :
- https://doi.org/10.15585/mmwr.mm7113a1